201 related articles for article (PubMed ID: 35428894)
41. Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies.
Wieszczy P; Kaminski MF; Franczyk R; Loberg M; Kobiela J; Rupinska M; Kocot B; Rupinski M; Holme O; Wojciechowska U; Didkowska J; Ransohoff D; Bretthauer M; Kalager M; Regula J
Gastroenterology; 2020 Mar; 158(4):875-883.e5. PubMed ID: 31563625
[TBL] [Abstract][Full Text] [Related]
42. Delivery of Cervical and Colorectal Cancer Screenings During the Pandemic in Community Health Centers: Practice Changes and Recovery Strategies.
Huguet N; Danna M; Baron A; Hall J; Hodes T; O'Malley J; Holderness H; Marino M; DeVoe JE; Cohen DJ
Med Care; 2023 Aug; 61(8):554-561. PubMed ID: 37310241
[TBL] [Abstract][Full Text] [Related]
43. Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany.
Brenner H; Altenhofen L; Stock C; Hoffmeister M
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):717-23. PubMed ID: 25218160
[TBL] [Abstract][Full Text] [Related]
44. Impact of moderate versus deep sedation on adenoma detection rate in index average-risk screening colonoscopies.
Turse EP; Dailey FE; Bechtold ML
Gastrointest Endosc; 2019 Sep; 90(3):502-505. PubMed ID: 31102644
[TBL] [Abstract][Full Text] [Related]
45. A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study.
Ishibashi F; Shida D; Suzuki S; Nagai M; Mochida K; Morishita T
Int J Colorectal Dis; 2022 Dec; 37(12):2543-2546. PubMed ID: 36383225
[TBL] [Abstract][Full Text] [Related]
46. A dedicated high-quality service for the management of patients with an inherited risk of colorectal cancer.
Adams LK; Qiu S; Hunt AK; Monahan KJ
Colorectal Dis; 2019 Aug; 21(8):879-885. PubMed ID: 30903731
[TBL] [Abstract][Full Text] [Related]
47. Adenoma detection rates in an opportunistic screening colonoscopy program in Iran, a country with rising colorectal cancer incidence.
Delavari A; Bishehsari F; Salimzadeh H; Khosravi P; Delavari F; Nasseri-Moghaddam S; Merat S; Ansari R; Vahedi H; Shahbazkhani B; Saberifiroozi M; Sotoudeh M; Malekzadeh R
BMC Gastroenterol; 2014 Nov; 14():196. PubMed ID: 25404264
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of Adenomas on Surveillance Colonoscopies for Patients with a History of Colonic Polyps of Unknown Histology.
Doyle JB; Krigel A; Lebwohl B
Dig Dis Sci; 2022 Jul; 67(7):3239-3243. PubMed ID: 34156591
[TBL] [Abstract][Full Text] [Related]
49. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
50. COVID-19 Pandemic Had Minimal Impact on Colonoscopy Completion After Colorectal Cancer Red Flag Sign or Symptoms in US Veterans.
Demb J; Liu L; Bustamante R; Dominitz JA; Earles A; Shah SC; Gawron AJ; Martinez ME; Gupta S
Dig Dis Sci; 2023 Apr; 68(4):1208-1217. PubMed ID: 36169748
[TBL] [Abstract][Full Text] [Related]
51. One-year review of real-time artificial intelligence (AI)-aided endoscopy performance.
Chin SE; Wan FT; Ladlad J; Chue KM; ; Teo EK; Lin CL; Foo FJ; Koh FH
Surg Endosc; 2023 Aug; 37(8):6402-6407. PubMed ID: 36932187
[TBL] [Abstract][Full Text] [Related]
52. Management of colorectal cancer screening backlog due to the COVID-19 pandemic: A retrospective analysis of the use of a colorectal cancer screening clinical-decision support tool in Argentina.
Pereyra L; Steinberg L; Lasa J; Marconi A; Calderwood AH; Pellisé M
Gastroenterol Hepatol; 2024 Feb; 47(2):140-148. PubMed ID: 36934841
[TBL] [Abstract][Full Text] [Related]
53. Impact of changes to the interscreening interval and faecal immunochemical test threshold in the national bowel cancer screening programme in England: results from the FIT pilot study.
Li SJ; Seedher T; Sharples LD; Benton SC; Mathews C; Gabe R; Sasieni P; Duffy SW
Br J Cancer; 2022 Nov; 127(8):1525-1533. PubMed ID: 35974099
[TBL] [Abstract][Full Text] [Related]
54. Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Based Screening : A Population-Based Cohort Study.
Wisse PHA; Erler NS; de Boer SY; den Hartog B; Oudkerk Pool M; Terhaar Sive Droste JS; Verveer C; Meijer GA; Lansdorp-Vogelaar I; Kuipers EJ; Dekker E; Spaander MCW
Ann Intern Med; 2022 Oct; 175(10):1366-1373. PubMed ID: 36162114
[TBL] [Abstract][Full Text] [Related]
55. Escrutinio para el cáncer de colon: ¿cuál fue el impacto en los primeros 2 años de la pandemia de COVID-19? Experiencia en una clínica privada ambulatoria.
Teramoto-Matsubara ÓT; Sobrino-Cossío S; Abdo-Francis JM; Vega-González F; Mateos-Pérez G
Cir Cir; 2023; 91(3):375-380. PubMed ID: 37441724
[TBL] [Abstract][Full Text] [Related]
56. Overuse of colonoscopy for colorectal cancer screening and surveillance.
Kruse GR; Khan SM; Zaslavsky AM; Ayanian JZ; Sequist TD
J Gen Intern Med; 2015 Mar; 30(3):277-83. PubMed ID: 25266407
[TBL] [Abstract][Full Text] [Related]
57. The use of the faecal immunochemical test during the COVID-19 pandemic to triage urgent colorectal cancer referrals.
Kamel F; Zulfiqar S; Penfold W; Weatherell S; Madani R; Nisar P; Bearn P
Colorectal Dis; 2022 Jun; 24(6):727-736. PubMed ID: 35297169
[TBL] [Abstract][Full Text] [Related]
58. The 'ins and outs' of colonoscopy at Wits Donald Gordon Medical Centre, South Africa: A practice audit of the outpatient endoscopy unit.
Bouter C; Barrow P; Bizos D; Bobat B; Devar J; Harran N; Joseph C; Mahomed A; Oettle J; Ramos J; Seabi M; Kgabage G; Gaylard P; Surridge D; Etheredge H; Fabian J; Lutrin D; Karlsson K
S Afr Med J; 2020 Nov; 110(12):1186-1190. PubMed ID: 33403963
[TBL] [Abstract][Full Text] [Related]
59. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.
Morris EJA; Goldacre R; Spata E; Mafham M; Finan PJ; Shelton J; Richards M; Spencer K; Emberson J; Hollings S; Curnow P; Gair D; Sebag-Montefiore D; Cunningham C; Rutter MD; Nicholson BD; Rashbass J; Landray M; Collins R; Casadei B; Baigent C
Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):199-208. PubMed ID: 33453763
[TBL] [Abstract][Full Text] [Related]
60. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme.
Larsen MB; Njor SH; Jensen TM; Ingeholm P; Andersen B
Scand J Gastroenterol; 2019 Aug; 54(8):1008-1014. PubMed ID: 31397598
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
